Arcturus sets up cameras around the edges of baseball stadiums to capture real-time action and generate a 3D digital clone of ...

The FDA bestows a Fast Track designation to ARCT's sa-mRNA vaccine candidate, ARCT-2304, for active immunization to prevent pandemic influenza A virus H5N1.

In a report released yesterday, Lili (Aurélie) Nsongo from Leerink Partners maintained a Hold rating on Arcturus Therapeutics ( ARCT – Research Report ), with a price target of $63.00. Discover ...

May 2025 is a prime time to explore the night sky, with Vesta taking center stage. Use our sky map to navigate the stars and planets, and don't miss the chance to observe this giant asteroid. Share ...

Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a commercial messenger RNA medicine company ...

The two brightest nighttime stars available in the Minnesota and Wisconsin sky are Sirius and Arcturus. April is the only ...

Arcturus Therapeutics Holdings has won U.S. Food and Drug Administration fast-track designation for its ARCT-2304 pandemic flu vaccine candidate.

Guggenheim analyst Seamus Fernandez lowered the firm’s price target on Arcturus Therapeutics (ARCT) to $45 from $71 and keeps a Buy rating on ...

One of the first major meteor showers of the year will coincide with Earth Day this year, offering a heavenly experience for ...

Arcturus Therapeutics Holdings Inc. ARCT announced that the FDA has granted a Fast Track designation to its self-amplifying mRNA (sa-mRNA) vaccine candidate, ARCT-2304, for active immunization to ...

Nestled deep in the Nubian Desert of southern Egypt lies a prehistoric relic that has reshaped our understanding of ancient ...